Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone marrow failure: pathophysiology and management

P Jacobs1

  • 1Department of Haematology, Wynberg Hospital, Cape Town, South Africa.

Disease-A-Month : DM
|April 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nitric oxide expression in the spleen, but not in the liver, correlates with resistance to blood-stage malaria in mice.

Journal of immunology (Baltimore, Md. : 1950)·1995
Same author

Blunted erythropoietin response to anaemia in tuberculosis.

European journal of haematology·1995
Same author

Immune response of mice infected with Schistosoma mansoni is modulated by antifibrotic treatment.

Annals of tropical medicine and parasitology·1995
Same author

Bone marrow failure. Pathophysiology and management.

The Central African journal of medicine·1995
Same author

A comparison of intensive care unit utilization in Alberta and western Massachusetts.

Critical care medicine·1995
Same author

Role of macrophage-derived nitric oxide in suppression of lymphocyte proliferation during blood-stage malaria.

Journal of leukocyte biology·1995
Same journal

GLP-1 agonist and neuroprotection in Stroke and Parkinson's disease: A systematic review.

Disease-a-month : DM·2026
Same journal

GLP-1 receptor agonists for weight management and potential thromboembolic risk reduction in high risk population with cancer, diabetes, cardiovascular disease: A systematic review.

Disease-a-month : DM·2026
Same journal

Periodontal disease and diabetic kidney disease: A comprehensive analysis.

Disease-a-month : DM·2026
Same journal

Foreword for Glucagon-like peptide-1 receptor agonists (GLP-1) and its promise for potential benefits.

Disease-a-month : DM·2026
Same journal

Foreword for insulin autoimmune syndrome (Hirata Disease): An updated review of epidemiology, pathophysiology, clinical features, diagnosis, and management.

Disease-a-month : DM·2026
Same journal

Foreword for periodontal disease and diabetic kidney disease: A comprehensive analysis.

Disease-a-month : DM·2026
See all related articles

Bone marrow failure, a reduction in cellular output, can be congenital or acquired and impacts hematopoietic and immunologic integrity. Management ranges from growth factors to bone marrow transplantation, informed by understanding stem cell dynamics.

Area of Science:

  • Hematology
  • Immunology
  • Stem Cell Biology

Background:

  • Bone marrow maintains hematopoietic and immunologic integrity.
  • Bone marrow failure is a reduction in cellular output due to insults.
  • Failure can be congenital or acquired, impacting cell lines and reversibility.

Purpose of the Study:

  • To classify bone marrow failure pathophysiologically.
  • To explain the management strategies for bone marrow failure.
  • To elucidate the dynamic nature of blood formation and stem cell roles.

Main Methods:

  • Pathophysiological classification of bone marrow failure.
  • Review of radiobiology models and bone marrow cultures.
  • Utilizing in-bred mouse strains for allogeneic transplantation studies.

Related Experiment Videos

Main Results:

  • Bone marrow failure categorized into congenital and acquired defects.
  • Management strategies identified based on natural history.
  • Key observations include stem cell roles, stroma participation, and recovery post-irradiation.

Conclusions:

  • Understanding blood formation dynamics, including stem cells and the microenvironment, is crucial.
  • Bone marrow failure has diverse causes but can be managed through targeted therapies.
  • Further research is needed to clarify the intricate processes of hematopoietic regulation.